Power wheelchair — group 2 denied as non-formulary by UnitedHealthcare?

Under UnitedHealthcare's Commercial medical policy, mobility devices including manual wheelchairs, electric wheelchairs, transfer chairs, scooters/power-operated vehicles (POV), canes, and walkers are a covered health care service when medically necessary. The policy aligns with CMS LCD L33789, which establishes that the beneficiary must have a mobility limitation that significantly impairs his/her ability to participate in one or more mobility-related activities of daily living (MRADLs) such as toileting, feeding, dressing, grooming, and bathing in customary locations in the home — a limitation that prevents the beneficiary from accomplishing an MRADL entirely, places the beneficiary at heightened risk of morbidity or mortality, or prevents completing an MRADL within a reasonable time frame ; additionally, the mobility limitation cannot be sufficiently and safely resolved by an appropriately fitted cane or walker, and the beneficiary does not have sufficient upper extremity function to self-propel an optimally-configured manual wheelchair in the home to perform MRADLs during a typical day. Use of a power wheelchair must significantly improve the beneficiary's ability to participate in MRADLs and the beneficiary will use it in the home (for severe cognitive/physical impairments, participation in MRADLs may require caregiver assistance), and the beneficiary has not expressed an unwillingness to use a power wheelchair in the home. For a Group 2 standard PWC, a Group 2 PWC (K0820, K0821, K0822, K0823, K0824, K0825, K0826, K0827, K0828, K0829) is covered if all of the coverage criteria (a)-(e) for a PWC are met and the wheelchair is appropriate for the beneficiary's weight. For a Group 2 Single Power Option PWC, all coverage criteria (a)-(e) must be met, plus the beneficiary meets coverage criteria for a power tilt or recline seating system OR requires a drive control interface other than a hand or chin-operated standard proportional joystick (examples include head control, sip and puff, switch control) , and a specialty evaluation must be performed by a licensed/certified medical professional (PT, OT, or practitioner with rehab wheelchair training) with no financial relationship with the supplier, and the wheelchair must be provided by a supplier that employs a RESNA-certified Assistive Technology Professional (ATP) with direct, in-person involvement in the wheelchair selection. DME has a reasonable useful lifetime (RUL) of 5 years , and payment is made for only one wheelchair at a time; backup chairs are denied as not reasonable and necessary.

- **Document MRADL impact in detail**: Provide a clinician note specifying which MRADLs (toileting, feeding, dressing, grooming, bathing) the patient cannot complete or completes only with heightened morbidity/mortality risk, directly mapping to the LCD L33789 definition of a qualifying mobility limitation . - **Stepwise rule-out of lesser devices**: Submit PT/OT documentation explaining why a cane, walker, and optimally-configured manual wheelchair each fail — addressing strength, endurance, ROM, coordination, pain, or upper-extremity deformity per the LCD's enumerated upper-extremity assessment factors (strength, endurance, range of motion, coordination, pain, deformity or absence of one or both upper extremities) . - **Provide compliant face-to-face and WOPD**: Attach the dated face-to-face mobility examination note and the signed Standard Written Order before delivery; cite Final Rule 1713's requirement of a face-to-face encounter and Written Order Prior to Delivery as satisfied. - **Include RESNA ATP and independent specialty evaluation**: For Group 2 Single Power Option chairs, include both the ATP credential attestation and the independent PT/OT specialty evaluation, satisfying the requirement that a licensed PT/OT with no financial relationship to the supplier perform the specialty evaluation and that a RESNA-certified ATP have direct involvement in wheelchair selection . - **Demonstrate in-home use**: Document home assessment showing adequate access between rooms and maneuvering space, and explicitly state the device will be used in the home to meet the requirement that the beneficiary's home provides adequate access and that the power wheelchair will significantly improve the beneficiary's ability to participate in MRADLs in the home . - **Justify Group 2 over Group 1**: If denied as needing only a Group 1, document the patient's weight against capacity limits or, for Single Power Option, the medical necessity of power tilt/recline (e.g., pressure ulcer risk, inability to perform a functional weight shift) or alternative drive control interface per LCD L33789 Group 2 Single Power Option criteria including need for non-standard drive control such as head control, sip and puff, or switch control . - **Replacement vs. repair**: For replacement requests, document the 5-year RUL and that the existing chair cannot be repaired or no longer meets the patient's needs, citing the 5-year reasonable useful lifetime standard and UHC's allowance for upgrades when the member's condition changes (e.g., impaired function necessitates an upgrade to a power wheelchair from a manual one) .

## Why UnitedHealthcare Denied Your Group 2 Power Wheelchair as "Non-Formulary"

A "non-formulary" label on a Group 2 PWC (HCPCS K0820–K0829) is almost always a miscoded denial. Formularies govern drugs; DME is governed by UnitedHealthcare's Mobility Devices, Options, and Accessories Commercial and Individual Exchange Medical Policy, which mirrors CMS LCD L33789 and the associated Policy Article A52498. When UHC's claims engine spits out "non-formulary," it typically means one of three things: (1) the supplier billed a Group 2 code where the documentation only supports Group 1 (K0813–K0816), (2) the ATP/PT-OT specialty evaluation chain required for Single Power Option Group 2 codes (K0835–K0843) is missing, or (3) the request was routed through Optum's DME benefit gate without the in-home assessment narrative. Treat the denial as a medical-necessity dispute, not a drug-tier appeal.

## The Mechanic Driving the Denial

UHC requires all of criteria (a)–(e) of the PWC base rule plus the Group 2-specific overlays. The high-frequency failure points are the cane/walker rule-out (criterion b), manual wheelchair self-propulsion rule-out (criterion c), and the in-home use attestation (criterion e). For Single Power Option chairs, UHC additionally requires documentation that the beneficiary qualifies for power tilt/recline or an alternative drive interface (head, sip-and-puff, switch), AND that the supplier employs a RESNA-certified ATP with direct in-person involvement. Missing the ATP signature alone is sufficient to trigger an automated denial that surfaces as "non-formulary" or "not a covered benefit."

## How to Reframe the Appeal

File through UHC's standard medical appeal channel (not OptumRx — this is DME, not pharmacy). Cite the policy by name and version date, and anchor every clinical fact to a specific LCD L33789 criterion. Attach: the LCMP/ATP specialty eval, the home assessment, the face-to-face encounter note signed within 6 months by the ordering practitioner, and the 7-element written order. If you are on an ERISA plan, invoke 29 CFR §2560.503-1(g) to demand the specific clinical rationale and the reviewer's credentials — UHC must disclose the internal rule applied. For Medicare Advantage members, 42 CFR §422.566 governs the organization determination and §422.568 sets the 14-day standard / 72-hour expedited timeline; cite Wit v. UBH (N.D. Cal. 2019, aff'd in part 9th Cir. 2023) where Optum-affiliated entities were held to generally accepted clinical standards, not internally narrower criteria.

## Tactical Tip

Before filing, pull the supplier's claim to confirm the HCPCS code. If they billed K0823 but the eval only supports K0813, the fastest path is a corrected claim, not an appeal. If coding is correct, request UHC's medical policy ID and version in writing and force a peer-to-peer with a physician reviewer board-certified in PM&R — generalists routinely miss the MRADL framework. File a parallel complaint with your state DOI if UHC refuses to identify the policy basis within 30 days.